JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2025, 74(3):194-198 | DOI: 10.36290/csf.2025.033

Periodontitis: pharmacist's options in its prevention and treatment

Lucie Hromčík Brunclíková

Periodontitis is the most common non-communicable inflammatory disease of humans. Although it affects the periodontal apparatus, its prevention and treatment are not solely the responsibility of the dentist and the dental hygienist. The pharmacist, as part of a multidisciplinary team, plays a role in supporting the patient's dental health and in identifying and educating at-risk patients. Increasing pharmacists' competence in the care of patients with periodontitis could lead to a reduction in its incidence and more effective treatment.

Keywords: periodontitis, dental plaque, smoking, diabetes, pharmacist.

Accepted: September 15, 2025; Published: October 2, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hromčík Brunclíková L. Periodontitis: pharmacist's options in its prevention and treatment. Čes. slov. farm. 2025;74(3):194-198. doi: 10.36290/csf.2025.033.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 40 CZK

    References

    1. Mann RS, Marcenes W, Gillam DG, et al. Is there a role for community pharmacists in promoting oral health? Br Dent J. 2015;218(5):E10. Go to original source... Go to PubMed...
    2. Kassebaum NJ, Smith AGC, Bernabé E, et al. Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990-2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors. J Dent Res. 2017;96(4):380-387. Go to original source... Go to PubMed...
    3. Billings M, Holtfreter B, Papapanou PN, et al. Age-dependent distribution of periodontitis in two countries: Findings from NHANES 2009 to 2014 and SHIP-TREND 2008 to 2012. J Periodontol. 2018;89 Suppl 1(Suppl 1):S140-S158. Go to original source... Go to PubMed...
    4. Sedghi LM, Bacino M, Kapila YL. Periodontal Disease: The Good, The Bad, and The Un­known. Front Cell Infect Microbiol. 2021;11:766944. Go to original source... Go to PubMed...
    5. Bhuyan R, Bhuyan SK, Mohanty JN, et al. Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms. Biomedicines. 2022;10(10):2659. Go to original source... Go to PubMed...
    6. Carrassi A, Cortellini P, Trombelli L, et al. Atlas of Periodontology and Implant Therapy. Chicago: Quintessence Publishing; 2019.
    7. Könönen E, Gursoy M, Gursoy UK. Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med. 2019;8(8):1135. Go to original source... Go to PubMed...
    8. Newman MG, Takei HH, Klokkevold PR, et al. Carranza's Clinical Periodontology. 12th ed. St. Louis, Missouri: Elsevier Saunders; 2015.
    9. Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis - The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47:4-60. Go to original source... Go to PubMed...
    10. Van Swaaij BWM, van der Weijden GAF, Bakker EWP, et al. Does chlorhexidine mouthwash, with an anti-discoloration system, reduce tooth surface discoloration without losing its efficacy? A systematic review and meta-analysis. Int J Dent Hyg. 2020;18(1):27-43. Go to original source... Go to PubMed...
    11. Poppolo Deus F, Ouanounou A. Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects. Int Dent J. 2022;72(3):269-277. Go to original source... Go to PubMed...
    12. Radu CM, Radu CC, Bochiș SA, et al. Revisiting the Therapeutic Effects of Essential Oils on the Oral Microbiome. Pharmacy (Basel). 2023;11(1):33. Go to original source... Go to PubMed...
    13. Králíková E, Býma S, Cífková R, et al. Doporučení pro léčbu závislosti na tabáku. Cas Lek Cesk. 2005;144(5):327-333. [Internet]. [cited 2025-05].

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.